An analysis found that on average, health plans would save $4,162 per patient each year if they switched to clinically equivalent single-tablet regimens. Meanwhile, a coalition of conservative groups is asking President Donald Trump to withdraw his plan to curb high drug costs, arguing it will hurt innovation by creating "price controls."
from Kaiser Health News https://ift.tt/2FNLutg
November 29, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Defying NRA, Florida Lawmakers Send Gun Control Legislation To Governor’s DeskAlthough the legislation falls short of many of the demands from students affected by the Parkland shooting and other advocates, if it is signed the bill will be the first successful gun control measure in Florida in more tha… Read More
First Edition: March 8, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News http://ift.tt/2FpkyLQ … Read More
Drugmakers’ ‘Sham Transactions’ With Tribes To Game Patent System Targeted By LawmakersThe latest legislation introduced in the Senate would limit the ability of a company to transfer patent rights to a foreign country or under legal claims of tribal sovereign immunity. from Kaiser Health News http://ift.tt/2o… Read More
FDA Chief Blasts ‘Rigged System’ Of Complex, Secret Deals That Keeps Generics Off Market, Hurts PatientsFDA Commissioner Scott Gottlieb's sharp words for the pharmaceutical industry is seen as a strong signal of his interest in curbing high drug costs. from Kaiser Health News http://ift.tt/2Iaix82 … Read More
As Settlement Efforts Falter In Massive Case Against Opioid-Makers, Judge Tells Sides To Prep For LitigationU.S. District Judge Dan Polster is overseeing a case that consolidated more than 350 lawsuits from cities and states across the country against drugmakers for their role in the opioid epidemic. Although Polster has been pushi… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment